Business Segments WuXi AppTec Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 15/05/2026			5-day change	1st Jan Change
103.13 ^CNY	+0.12%		-3.44%	+13.78%

15/05	WuXi AppTec Plans 6.8 Billion Yuan Zero-Coupon Convertible Bond Issue	MT
15/05	Wuxi Apptec to issue convertible bonds	RE

Breakdown by Business Segment (CNY)

Fiscal Period: December	2021	2022	2023	2024	2025
Life Sciences Tools and Services
Chemical Business	1.41TCr	2.88TCr	2.92TCr	2.91TCr	3.65TCr
Gross Profit	556.52Cr	1.15TCr	1.3TCr	1.35TCr	1.89TCr
Test Business	452.51Cr	571.87Cr	653.97Cr	567.07Cr	404.17Cr
Gross Profit	143.45Cr	199.5Cr	244.57Cr	185.61Cr	118.24Cr
Biology Business	198.51Cr	247.51Cr	255.26Cr	254.39Cr	267.72Cr
Gross Profit	77Cr	96Cr	103Cr	96Cr	93Cr
High-end therapy CTDMO business (Wu Xi ATU)	102.64Cr	130.8Cr	130.96Cr	-	-
Gross Profit	-2.08Cr	-8.74Cr	-13Cr	-	-
Clinical Research and Other CRO Services	-	-	-	-	-
Gross Profit	-	-	-	-	-
US District Laboratory Services	-	-	-	-	-
Gross Profit	-	-	-	-	-
Laboratory Services in China	-	-	-	-	-
Gross Profit	-	-	-	-	-
Discontinued Operations	-	-	-	-	203.53Cr
Gross Profit	-	-	-	-21Cr	42Cr
Others	-	-	-	65Cr	24Cr
Gross Profit	-	-	-	20Cr	20Cr
Unallocated Other	2.75Cr	3.36Cr	4.1Cr	-	-
Gross Profit	1.31Cr	1.57Cr	2.1Cr	-	-
Pharmaceutical Contract Research Organization
Domestic New Drug Research and Development Service Unit (Wu Xi DDSU)	125.1Cr	97Cr	73Cr	-	-
Gross Profit	55Cr	25Cr	26Cr	-	-

Geographical breakdown of sales (CNY)

Fiscal Period: December	2021	2022	2023	2024	2025
Overseas	-	-	3.3TCr	3.09TCr	3.8TCr
Total Assets	-	-	-	-	-
China	580.2Cr	752.6Cr	733.05Cr	704.76Cr	546.66Cr
Total Assets	-	-	-	-	-
Discontinued Operations	-	-	-	-	203.53Cr
Asia	-	-	-	-	-
Total Assets	-	-	-	-	-
Rest of World	123.4Cr	151.2Cr	-	-	-
Asia (Except China)	-	-	-	-	-
Europe	371.9Cr	443.2Cr	-	-	-
United States	1.21TCr	2.59TCr	-	-	-